Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis. - Wikidata - wikimedia - TriplyDB

Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.

Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.

http://www.wikidata.org/entity/Q46123241

about

Autoimmune Myopathies: Where Do We Stand?Emerging therapeutic options for sporadic inclusion body myositis Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory Myopathies Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies Update in inclusion body myositis New autoantibody detection technologies yield novel insights into autoimmune disease Diagnosis and classification of idiopathic inflammatory myopathies.Immunotherapies for Immune-Mediated Myopathies: A Current Perspective Immune and myodegenerative pathomechanisms in inclusion body myositis Sporadic inclusion body myositis: the genetic contributions to the pathogenesis.Treatment of sporadic inclusion body myositis with bimagrumab Ongoing developments in sporadic inclusion body myositis Sporadic inclusion body myositis: new insights and potential therapy.Discovery of protein interactions using parallel analysis of translated ORFs (PLATO).Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis.Misdiagnosis of inclusion body myositis: two case reports and a retrospective chart review Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies.Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis.Diagnosis, pathogenesis and treatment of myositis: recent advances.Muscle disorders: the latest investigations.Inclusion body myositis: from immunopathology and degenerative mechanisms to treatment perspectives.Understanding and applying tyrosine biochemical diversity.Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies.Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken.Myositis Mimics.Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.Pathomechanisms of anti-cytosolic 5'-nucleotidase 1A autoantibodies in sporadic inclusion body myositis.Sporadic inclusion body myositis - a myodegenerative disease or an inflammatory myopathy.Diagnostic criteria for inclusion body myositis.Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum.Integrated classification of inflammatory myopathies.Autoimmune Myopathies.Association of inclusion body myositis with T cell large granular lymphocytic leukaemia.Genetics in inclusion body myositis.Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement.Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.New ways to subclassify patients with myositis.

P2860

Q26744554-D4D3C800-B7C0-480C-BD08-5DC606D4FA6E Q26786571-E19719A9-AEA3-4D9F-8E19-B4345069A19F Q26798209-94C7F1E3-7E56-4B19-9EDA-A87CE41F20D0 Q26824432-31C674A0-C275-47AB-BCEC-7A91FFC6D40F Q26829906-717144EF-77A8-4063-B155-5A62F76F015C Q27000173-23F1EA40-E033-4976-8E35-53D532D0E184 Q30249522-38DFC8B5-B880-4D8E-AA42-C40AB17AB6B0 Q30699742-814EDFE6-0FF5-40AD-87DE-934B1B379885 Q33753870-13BBBFFD-7CCF-4153-B1D8-04C50657047C Q33806912-3EE63608-9DA8-45F1-B3FC-01BCB68BA7E6 Q34446951-A0287736-72B7-4655-8448-C60357E516FE Q34519540-271E1057-B49D-4EDD-B464-335793520CFD Q34591787-CCD806B8-0D4A-4F9B-AA16-77A946095DDA Q35066562-9047AA51-7124-4EBD-8307-6917B9D63026 Q35213944-2AAE6152-0F09-43DE-8BCA-C813E40BB5DF Q35944757-966F732D-4A0C-4791-AA7D-5984C88B4949 Q36335887-19E2D2F0-6C0D-43AB-91B8-0C9F4BAAB3A1 Q36424500-B260400A-6241-4F14-BA46-70FDEA2513BA Q36953554-A2EBD5D0-DC46-4920-BB67-6AA990794A12 Q37421042-FAB1DF9B-4984-4293-BBE5-EEE636080A9D Q38131849-B55D3008-33E9-47CA-AE3A-BF8F5107E053 Q38134153-7511D96A-FAA8-4825-8B9A-38840716BD01 Q38153797-88E5E1F0-AF64-49FA-B147-3B1A719FFFA7 Q38195522-295A8EF9-C569-4141-94F0-3AEF4F6CED13 Q38281749-493D962C-7A69-4803-9024-2A5DABE194E3 Q38314711-BF08AB48-45B2-4DF4-A314-9D7CFCD8F26C Q38569863-13ABB3A2-D650-4A77-B966-7B44558A9FFB Q38646384-E88D8F81-9497-41BB-B953-463FF9914122 Q38711585-58B0A9B6-D29E-4CBD-ABB7-A36C7BB1B10E Q38767200-A9FD839C-B42B-43FF-948E-8C609B38121B Q38793315-EA9D13CA-D102-4C06-94F7-35ADEBA58EBA Q38999120-AC5872E8-BC15-4C40-83CE-5F6941FAA114 Q39021882-25881F54-767F-42AD-8E2A-0920D2047631 Q39027323-FC03FB94-7CF5-4D3C-A73F-4ED6BA5831B6 Q39030495-03B30CFA-6EBA-49C5-9891-4C2A259C9B08 Q39964765-08C9B3D9-79B0-4552-A7CD-69F531A6E32D Q40094784-1818C3D1-BA98-4C94-A818-B93CA3F19EBA Q46195557-224BE749-EA8C-4E87-B1F0-9D67829FF259 Q47648163-79B46BB9-8756-40EF-97AE-263492B769CF Q47868107-8208D047-9032-49E3-B174-E90E4A8C7E93

P2860

Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.

http://www.wikidata.org/entity/Q46123241

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.

@en

Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.

@nl

type

label

Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.

@en

Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.

@nl

prefLabel

Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.

@en

Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.

@nl

P1433

Q46123241-3E21EC39-3287-4EF1-A25E-9EF88507B5F7

P1476

Q46123241-41F31D17-5E91-4036-9A7B-0F36EEE9399A

P2093

Q46123241-1448E04F-648C-4DCD-BDFD-F67D3E5AD581

Q46123241-33424C4E-FCB3-42D7-90A1-5C0DC52547B3

Q46123241-3689E268-35C4-4651-BA4C-DEB687F67581

Q46123241-43411693-61F8-40DE-9963-3AF1003600E9

Q46123241-472B13C2-31FE-4ED0-89AD-9EAF83D0C58C

Q46123241-62C3040C-BD05-4414-920F-36193958BAE4

Q46123241-A33E83E7-1DAE-4644-95CE-036C46B23B0D

Q46123241-B8C1A122-087C-41BD-8442-E0A31F42DC6E

Q46123241-B9BACB9C-8346-4E98-B20B-90621DEACB9D

Q46123241-D4BA1A54-96DE-4760-B055-82383BAB9879

P2860

Q46123241-07E00F2E-DA41-4659-A904-84460D03A096

Q46123241-14E3F24A-81A5-4731-904D-7443E554FE82

Q46123241-1E85EA9B-69CA-4E95-BA5A-14FE24BE7662

Q46123241-342D1DCA-18E0-49E0-9A0F-0165D7858821

Q46123241-3F70DEE0-1BF4-44EA-ABC8-9D95D6D44FE9

Q46123241-40563723-E9F9-44BD-8F19-86A0AFB8B567

Q46123241-5C2170AC-0EB1-454D-B3F8-2A3B795606C2

Q46123241-6181087C-49C3-4A67-86DC-89277A075DD5

Q46123241-6571E7EA-4D6D-48A3-B7DE-30D199E14383

Q46123241-6AE76248-1BB0-4B93-91EA-EF9366A8BA54

P304

Q46123241-BFB405C7-0B38-4747-8A4F-6015F4911B29

P31

Q46123241-7A293614-CFA5-4F97-8E48-5F5BA9B940D1

P356

Q46123241-1B00C216-2D10-44EF-B8E0-40444A585FB0

P433

Q46123241-8CD65CA6-17A9-45A2-B34C-513CD2D555AA

P478

Q46123241-CCA30622-4B0B-40CA-8875-D276B33A6FB2

P50

Q46123241-9D8B2DAD-665A-4745-A439-690920CF932C

Q46123241-A6A1D5DE-7F8D-41C3-81E2-691D59628886

Q46123241-EC367AAD-2FB9-4DDB-A9F2-7638BBC3B2C0

P577

Q46123241-B6EEA85E-C051-4540-AC18-9F2C5F549D66

P5875

Q46123241-B56A863C-8386-44AA-96F3-74627E59A34F

P698

Q46123241-5051B86E-9A6F-4501-8342-1A6C70FF9E37

P921

Q46123241-EED8AA30-313D-4707-A3B7-CBED51545F49

P356

P1433

Annals of Neurology

P1476

Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis

@en

P2093

Annemarie van der Heijden

http://www.w3.org/2001/XMLSchema#string

Bas J A van Hoeve

http://www.w3.org/2001/XMLSchema#string

Baziel G van Engelen

http://www.w3.org/2001/XMLSchema#string

Ger J M Pruijn

http://www.w3.org/2001/XMLSchema#string

Helenius J Schelhaas

http://www.w3.org/2001/XMLSchema#string

Helma Pluk

http://www.w3.org/2001/XMLSchema#string

Judith Stammen-Vogelzangs

http://www.w3.org/2001/XMLSchema#string

Karina Gheorghe

http://www.w3.org/2001/XMLSchema#string

Sander H J van Dooren

http://www.w3.org/2001/XMLSchema#string

Snjolaug Arnardottir

http://www.w3.org/2001/XMLSchema#string

P2860

A local antigen-driven humoral response is present in the inflammatory myopathies.

Sporadic inclusion body myositis: a continuing puzzle.

Nonimmune mechanisms of muscle damage in myositis: role of the endoplasmic reticulum stress response and autophagy in the disease pathogenesis.

Autoantibodies against a 43 KDa muscle protein in inclusion body myositis

Theories of the pathogenesis of inclusion body myositis.

Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis.

Inflammatory, immune, and viral aspects of inclusion-body myositis.

Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition.

Polymyositis and dermatomyositis.

Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies.

P304

397-407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.23822

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P50

Ingrid E Lundberg

P577

2013-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235787668

http://www.w3.org/2001/XMLSchema#string

P698

23460448

http://www.w3.org/2001/XMLSchema#string

P921